Why is Astrazeneca Phar falling/rising?

As of 31-Jul, Astrazeneca Pharma India Ltd's stock price is currently at 9,197.30, reflecting a decrease of 93.7 points, or 1.01%. The stock has recently experienced a trend reversal, falling after three consecutive days of gains. Despite this decline, it has outperformed its sector by 0.48% today and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has increased by 1.87%, and it has shown strong performance over longer periods, with a year-to-date return of 25.39% and a one-year return of 30.94%. The company has demonstrated high management efficiency with a return on equity of 19.06% and has reported significant growth in net profit, which could support its valuation despite the current price drop.
In the broader market context, Astrazeneca Pharma's recent performance contrasts positively with the Sensex, which has declined by 1.22% over the past week. This indicates that the stock has maintained relative strength against the benchmark. However, the company faces risks such as poor long-term growth prospects, as indicated by an annual operating profit growth rate of 15.95% over the last five years and a high price-to-book value ratio of 29.8, suggesting it is trading at a premium compared to peers. While the stock has generated substantial returns over the past year, the elevated PEG ratio of 3.3 indicates that its growth may not justify its current valuation, contributing to the recent price decline.